The nuclear receptor coactivator PGC-1alpha exhibits modes of interaction with the estrogen receptor distinct from those of SRC-1 - PubMed (original) (raw)
The nuclear receptor coactivator PGC-1alpha exhibits modes of interaction with the estrogen receptor distinct from those of SRC-1
Anne Bourdoncle et al. J Mol Biol. 2005.
Abstract
Estrogen receptor (ER) function is mediated by multi-domain co-regulator proteins. A fluorescently labelled fragment of the human PGC-1alpha co-regulator (residues 91-408) bearing the two motifs most strongly implicated in interactions with nuclear receptors (NR box2 and NR box3), was used to characterize in vitro binding of PGC-1alpha to ER. Anisotropy measurements revealed that the affinity of this PGC-1alpha fragment for human ERalpha and beta was fairly strong in the presence of estradiol (approximately 5 nM), and that unlike a similar fragment of SRC-1 (570-780), PGC-191-408 exhibited ligand-independent interactions with ER, particularly with ERbeta (Kd approximately 30 nM). Competition experiments of the complex between ERalpha and fluorescently labelled PGC-1 91-408 with unlabelled SRC-1 570-780 showed that PGC-1 91-408 was an efficient competitor of SRC-1 570-780, while the inverse was not true, underscoring their distinct modes of binding. The anisotropy data provide strong evidence for a ternary complex between ERalpha, SRC-1 570-780 and PGC-1 91-408. GST-pull-down experiments with deletion mutants of ERalpha revealed that the constitutive binding of PGC-1 91-408 requires the presence of the linker domain between the DNA binding and ligand binding domains (DBD and LBD). Homology modeling studies of the different regions of full length PGC-1alpha confirmed the lack of compact tertiary structure of the N-terminal region bearing the NR box motifs, and suggested a slightly different mode of interaction compared to the NR box motifs of SRC-1. They also provided reasonable structural models for the coiled-coil dimerization motif at residues 633-675, as well as the C-terminal putative RNA binding domain, raising important questions concerning the stoichiometry of its complex with the nuclear receptors.
Similar articles
- Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop.
Greschik H, Althage M, Flaig R, Sato Y, Chavant V, Peluso-Iltis C, Choulier L, Cronet P, Rochel N, Schüle R, Strömstedt PE, Moras D. Greschik H, et al. J Biol Chem. 2008 Jul 18;283(29):20220-30. doi: 10.1074/jbc.M801920200. Epub 2008 Apr 25. J Biol Chem. 2008. PMID: 18441008 - The human estrogen receptor alpha dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist structure.
Margeat E, Poujol N, Boulahtouf A, Chen Y, Müller JD, Gratton E, Cavailles V, Royer CA. Margeat E, et al. J Mol Biol. 2001 Feb 23;306(3):433-42. doi: 10.1006/jmbi.2000.4418. J Mol Biol. 2001. PMID: 11178903 - Distinct ligand-dependent and independent modes of thyroid hormone receptor (TR)/PGC-1α interaction.
Yuan C, Nguyen P, Baxter JD, Webb P. Yuan C, et al. J Steroid Biochem Mol Biol. 2013 Jan;133:58-65. doi: 10.1016/j.jsbmb.2012.09.001. Epub 2012 Sep 10. J Steroid Biochem Mol Biol. 2013. PMID: 22974658 - CAT in the HAT: catabolic inhibition by the histone acetyltransferase GCN5.
Liu Y, Montminy M. Liu Y, et al. Cell Metab. 2006 Jun;3(6):387-8. doi: 10.1016/j.cmet.2006.05.006. Cell Metab. 2006. PMID: 16753572 Review. - A structural biologist's view of the oestrogen receptor.
Pike AC, Brzozowski AM, Hubbard RE. Pike AC, et al. J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):261-8. doi: 10.1016/s0960-0760(00)00102-3. J Steroid Biochem Mol Biol. 2000. PMID: 11162934 Review.
Cited by
- PGC1α as a downstream effector of KDM5B promotes the progression of androgen receptor-positive and androgen receptor-negative prostate cancers.
Teramoto Y, Yang Z, Matsukawa T, Najafi MAE, Goto T, Miyamoto H. Teramoto Y, et al. Am J Cancer Res. 2024 Sep 15;14(9):4367-4377. doi: 10.62347/QWZY6886. eCollection 2024. Am J Cancer Res. 2024. PMID: 39417173 Free PMC article. - Dysregulation of PGC-1α-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and Opportunities.
McMeekin LJ, Fox SN, Boas SM, Cowell RM. McMeekin LJ, et al. Cells. 2021 Feb 9;10(2):352. doi: 10.3390/cells10020352. Cells. 2021. PMID: 33572179 Free PMC article. Review. - Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers.
Cotul EK, Zuo Q, Santaliz-Casiano A, Imir OB, Mogol AN, Tunc E, Duong K, Lee JK, Ramesh R, Odukoya E, Kesavadas MP, Ziogaite M, Smith BP, Mao C, Shapiro DJ, Park BH, Katzenellenbogen BS, Daly D, Aranda E, O'Neill JD, Walker C, Landesman Y, Madak-Erdogan Z. Cotul EK, et al. Cancers (Basel). 2020 Aug 24;12(9):2397. doi: 10.3390/cancers12092397. Cancers (Basel). 2020. PMID: 32847042 Free PMC article. - Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway.
Yang H, Yang R, Liu H, Ren Z, Kong F, Li D, Ma X. Yang H, et al. Onco Targets Ther. 2016 Jun 30;9:3963-73. doi: 10.2147/OTT.S103482. eCollection 2016. Onco Targets Ther. 2016. PMID: 27418839 Free PMC article. - The combination of Artemisia princeps Pamp, Leonurus japonicas Houtt, and Gardenia jasminoides Ellis fruit attenuates the exacerbation of energy, lipid, and glucose by increasing hepatic PGC-1α expression in estrogen-deficient rats.
Yang HJ, Kim MJ, Kwon DY, Moon BR, Kim AR, Kang S, Park S. Yang HJ, et al. BMC Complement Altern Med. 2016 May 23;16:137. doi: 10.1186/s12906-016-1109-x. BMC Complement Altern Med. 2016. PMID: 27216600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous